Filing Details
- Accession Number:
- 0001610717-23-000171
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-16 17:37:43
- Reporting Period:
- 2023-06-14
- Accepted Time:
- 2023-06-16 17:37:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1770787 | 10X Genomics Inc. | TXG | Laboratory Analytical Instruments (3826) | 455614458 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1786720 | Serge Saxonov | 10X Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton CA 94588 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2023-06-14 | 185 | $0.00 | 893,005 | No | 4 | G | Direct | |
| Class A Common Stock | Disposition | 2023-06-14 | 740 | $57.50 | 892,265 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2023-06-14 | 1,209 | $58.53 | 891,056 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2023-06-14 | 51 | $59.15 | 891,005 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | G | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Class A Common Stock | 27 | Indirect | See footnote |
| Class A Common Stock | 870 | Indirect | See footnote |
| Class A Common Stock | 183,350 | Indirect | See footnote |
| Class A Common Stock | 16,320 | Indirect | See footnote |
Footnotes
- The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022.
- This transaction was executed in multiple trades at prices ranging from $57.03 to $58.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $58.05 to $59.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $59.05 to $59.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
- The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
- The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
- The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.
Billionaire Hedge Funds
